(1->4)-beta-D-glucan multiple interactions ISO RGD:736695 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC38A2 mRNA CTD PMID:36331819 (R)-lipoic acid multiple interactions ISO RGD:736695 6480464 Thioctic Acid inhibits the reaction [arsenic trioxide results in increased expression of SLC38A2 mRNA] CTD PMID:23892647 1,2-dimethylhydrazine decreases expression ISO RGD:736695 6480464 1, 2-Dimethylhydrazine results in decreased expression of SLC38A2 mRNA CTD PMID:22206623 1,3,5-trinitro-1,3,5-triazinane increases expression EXP 6480464 cyclonite results in increased expression of SLC38A2 mRNA CTD PMID:25559034 17beta-estradiol affects expression ISO RGD:736694 6480464 Estradiol affects the expression of SLC38A2 mRNA CTD PMID:22574217 17beta-estradiol multiple interactions ISO RGD:736695 6480464 [Estradiol co-treated with Progesterone] results in increased expression of SLC38A2 mRNA CTD PMID:18556351 17beta-estradiol increases expression ISO RGD:736694 6480464 Estradiol results in increased expression of SLC38A2 mRNA CTD PMID:18556351 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:736695 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC38A2 mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC38A2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC38A2 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:736695 6480464 Tetrachlorodibenzodioxin affects the expression of SLC38A2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SLC38A2 mRNA CTD PMID:22298810 , PMID:34747641 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of SLC38A2 mRNA CTD PMID:21346803 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',4,4'-tetrachlorobiphenyl multiple interactions ISO RGD:736695 6480464 3 more ... CTD PMID:19467301 3,3',5-triiodo-L-thyronine increases expression EXP 6480464 Triiodothyronine results in increased expression of SLC38A2 mRNA CTD PMID:29357290 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:736695 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of SLC38A2 mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:736694 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SLC38A2 mRNA CTD PMID:28628672 4-hydroxyphenyl retinamide increases expression ISO RGD:736695 6480464 Fenretinide results in increased expression of SLC38A2 mRNA CTD PMID:28973697 4-phenylbutyric acid multiple interactions ISO RGD:736695 6480464 4-phenylbutyric acid inhibits the reaction [arsenite results in increased expression of SLC38A2 mRNA] CTD PMID:22215663 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of SLC38A2 mRNA CTD PMID:31881176 acrolein multiple interactions ISO RGD:736694 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of SLC38A2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of SLC38A2 mRNA CTD PMID:32699268 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of SLC38A2 mRNA CTD PMID:28959563 acrylamide increases expression ISO RGD:736694 6480464 Acrylamide results in increased expression of SLC38A2 mRNA CTD PMID:32763439 aflatoxin B1 decreases methylation ISO RGD:736694 6480464 Aflatoxin B1 results in decreased methylation of SLC38A2 gene CTD PMID:27153756 alpha-(methylamino)isobutyric acid multiple interactions ISO RGD:736695 6480464 SLC38A2 mutant form inhibits the reaction [arsenite results in increased transport of 2-(methylamino)isobutyric acid] CTD PMID:22215663 alpha-pinene multiple interactions ISO RGD:736694 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of SLC38A2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of SLC38A2 mRNA CTD PMID:32699268 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC38A2 mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of SLC38A2 mRNA CTD PMID:30779732 aristolochic acid A decreases expression ISO RGD:736694 6480464 aristolochic acid I results in decreased expression of SLC38A2 mRNA CTD PMID:33212167 arsane multiple interactions ISO RGD:736694 6480464 [Palmitic Acid co-treated with Arsenic] affects the expression of SLC38A2 mRNA CTD PMID:33736254 arsenic atom multiple interactions ISO RGD:736694 6480464 [Palmitic Acid co-treated with Arsenic] affects the expression of SLC38A2 mRNA CTD PMID:33736254 arsenite(3-) multiple interactions ISO RGD:736694 6480464 arsenite inhibits the reaction [G3BP1 protein binds to SLC38A2 mRNA] more ... CTD PMID:22215663 , PMID:32406909 arsenite(3-) increases expression ISO RGD:736695 6480464 arsenite results in increased expression of SLC38A2 mRNA CTD PMID:22215663 arsenite(3-) multiple interactions ISO RGD:736695 6480464 4-phenylbutyric acid inhibits the reaction [arsenite results in increased expression of SLC38A2 mRNA] more ... CTD PMID:22215663 arsenite(3-) increases expression ISO RGD:736694 6480464 arsenite results in increased expression of SLC38A2 mRNA CTD PMID:22215663 arsenous acid increases expression ISO RGD:736695 6480464 Arsenic Trioxide results in increased expression of SLC38A2 mRNA CTD PMID:23892647 arsenous acid multiple interactions ISO RGD:736695 6480464 salubrinal promotes the reaction [Arsenic Trioxide results in increased expression of SLC38A2 mRNA], Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of SLC38A2 mRNA] CTD PMID:23892647 benzatropine multiple interactions ISO RGD:736694 6480464 [Cuprizone co-treated with Benztropine] results in increased expression of SLC38A2 protein CTD PMID:34122009 benzene increases expression ISO RGD:736694 6480464 Benzene results in increased expression of SLC38A2 mRNA CTD PMID:20036648 more ... benzo[a]pyrene increases expression ISO RGD:736695 6480464 Benzo(a)pyrene results in increased expression of SLC38A2 mRNA CTD PMID:21569818 , PMID:22228805 benzo[a]pyrene affects methylation ISO RGD:736694 6480464 Benzo(a)pyrene affects the methylation of SLC38A2 promoter CTD PMID:27901495 benzo[a]pyrene diol epoxide I affects expression ISO RGD:736694 6480464 7 more ... CTD PMID:20382639 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:736694 6480464 7 more ... CTD PMID:17944540 , PMID:19150397 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SLC38A2 mRNA CTD PMID:18164116 bis(2-chloroethyl) sulfide affects expression EXP 6480464 Mustard Gas affects the expression of SLC38A2 mRNA CTD PMID:15651846 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC38A2 mRNA CTD PMID:25181051 more ... bisphenol A affects expression ISO RGD:736694 6480464 bisphenol A affects the expression of SLC38A2 mRNA CTD PMID:30903817 bisphenol F multiple interactions ISO RGD:736694 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SLC38A2 mRNA CTD PMID:28628672 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of SLC38A2 mRNA CTD PMID:32479839 cadmium atom multiple interactions ISO RGD:736695 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC38A2 mRNA CTD PMID:29373603 cadmium dichloride multiple interactions ISO RGD:736695 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC38A2 mRNA CTD PMID:29373603 caffeine affects phosphorylation ISO RGD:736694 6480464 Caffeine affects the phosphorylation of SLC38A2 protein CTD PMID:35688186 carbon nanotube increases expression ISO RGD:736695 6480464 Nanotubes more ... CTD PMID:25554681 carbonyl sulfide decreases expression EXP 6480464 carbonyl sulfide results in decreased expression of SLC38A2 mRNA CTD PMID:19395590 CGP 52608 multiple interactions ISO RGD:736694 6480464 CGP 52608 promotes the reaction [RORA protein binds to SLC38A2 gene] CTD PMID:28238834 chloropicrin affects expression ISO RGD:736694 6480464 chloropicrin affects the expression of SLC38A2 mRNA CTD PMID:26352163 chromium(6+) affects expression ISO RGD:736695 6480464 chromium hexavalent ion affects the expression of SLC38A2 mRNA CTD PMID:28472532 ciguatoxin CTX1B affects expression ISO RGD:736695 6480464 Ciguatoxins affects the expression of SLC38A2 mRNA CTD PMID:18353800 cisplatin increases expression ISO RGD:736694 6480464 Cisplatin results in increased expression of SLC38A2 mRNA CTD PMID:27594783 clobetasol increases expression ISO RGD:736695 6480464 Clobetasol results in increased expression of SLC38A2 mRNA CTD PMID:27462272 clofibrate multiple interactions ISO RGD:736695 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of SLC38A2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SLC38A2 mRNA] CTD PMID:17585979 copper(II) sulfate increases expression ISO RGD:736694 6480464 Copper Sulfate results in increased expression of SLC38A2 mRNA CTD PMID:19549813 crocidolite asbestos decreases expression ISO RGD:736694 6480464 Asbestos, Crocidolite results in decreased expression of SLC38A2 mRNA CTD PMID:29523930 crocidolite asbestos decreases expression ISO RGD:736695 6480464 Asbestos, Crocidolite results in decreased expression of SLC38A2 mRNA CTD PMID:29279043 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of SLC38A2 mRNA CTD PMID:27523638 Cuprizon multiple interactions ISO RGD:736694 6480464 [Cuprizone co-treated with Benztropine] results in increased expression of SLC38A2 protein CTD PMID:34122009 cyclosporin A decreases expression ISO RGD:736694 6480464 Cyclosporine results in decreased expression of SLC38A2 mRNA CTD PMID:25562108 dexamethasone multiple interactions ISO RGD:736695 6480464 [Dexamethasone co-treated with INS protein co-treated with PRL protein] results in increased expression of SLC38A2 mRNA CTD PMID:28174119 dexamethasone multiple interactions ISO RGD:736694 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SLC38A2 mRNA CTD PMID:28628672 dextran sulfate increases expression ISO RGD:736695 6480464 Dextran Sulfate results in increased expression of SLC38A2 mRNA CTD PMID:27920257 diarsenic trioxide increases expression ISO RGD:736695 6480464 Arsenic Trioxide results in increased expression of SLC38A2 mRNA CTD PMID:23892647 diarsenic trioxide multiple interactions ISO RGD:736695 6480464 salubrinal promotes the reaction [Arsenic Trioxide results in increased expression of SLC38A2 mRNA], Thioctic Acid inhibits the reaction [Arsenic Trioxide results in increased expression of SLC38A2 mRNA] CTD PMID:23892647 dichloromethane increases expression ISO RGD:736694 6480464 Methylene Chloride results in increased expression of SLC38A2 mRNA CTD PMID:20359517 doxorubicin affects response to substance ISO RGD:736694 6480464 SLC38A2 mRNA affects the susceptibility to Doxorubicin CTD PMID:16044152 epoxiconazole decreases expression ISO RGD:736695 6480464 epoxiconazole results in decreased expression of SLC38A2 mRNA CTD PMID:35436446 erythromycin estolate decreases expression EXP 6480464 Erythromycin Estolate results in decreased expression of SLC38A2 mRNA CTD PMID:24412560 ethanol affects expression ISO RGD:736695 6480464 Ethanol affects the expression of SLC38A2 mRNA CTD PMID:30319688 ethanol multiple interactions ISO RGD:736695 6480464 Ethanol affects the expression of and affects the splicing of SLC38A2 mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO RGD:736694 6480464 Ethyl Methanesulfonate results in increased expression of SLC38A2 mRNA CTD PMID:23649840 ethylbenzene increases expression ISO RGD:736694 6480464 ethylbenzene results in increased expression of SLC38A2 mRNA CTD PMID:20359517 fenvalerate decreases expression ISO RGD:736695 6480464 fenvalerate results in decreased expression of SLC38A2 mRNA CTD PMID:28369636 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of SLC38A2 mRNA CTD PMID:34044035 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of SLC38A2 mRNA CTD PMID:18035473 fluoranthene multiple interactions ISO RGD:736695 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of SLC38A2 mRNA CTD PMID:28329830 flusilazole increases expression EXP 6480464 flusilazole results in increased expression of SLC38A2 mRNA CTD PMID:28263823 formaldehyde increases expression ISO RGD:736694 6480464 Formaldehyde results in increased expression of SLC38A2 mRNA CTD PMID:23649840 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SLC38A2 mRNA CTD PMID:22061828 hexadecanoic acid affects expression ISO RGD:736694 6480464 Palmitic Acid affects the expression of SLC38A2 mRNA CTD PMID:33736254 hexadecanoic acid multiple interactions ISO RGD:736694 6480464 [Palmitic Acid co-treated with Arsenic] affects the expression of SLC38A2 mRNA CTD PMID:33736254 indometacin multiple interactions ISO RGD:736694 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SLC38A2 mRNA CTD PMID:28628672 inulin multiple interactions ISO RGD:736695 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SLC38A2 mRNA CTD PMID:36331819 ivermectin decreases expression ISO RGD:736694 6480464 Ivermectin results in decreased expression of SLC38A2 protein CTD PMID:32959892 lead diacetate decreases expression ISO RGD:736695 6480464 lead acetate results in decreased expression of SLC38A2 mRNA CTD PMID:21829687 leflunomide increases expression ISO RGD:736694 6480464 leflunomide results in increased expression of SLC38A2 mRNA CTD PMID:28988120 levofloxacin increases expression EXP 6480464 Levofloxacin results in increased expression of SLC38A2 mRNA CTD PMID:24136188 lipoic acid multiple interactions ISO RGD:736695 6480464 Thioctic Acid inhibits the reaction [arsenic trioxide results in increased expression of SLC38A2 mRNA] CTD PMID:23892647 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of SLC38A2 mRNA CTD PMID:16415329 lipopolysaccharide multiple interactions EXP 6480464 Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of SLC38A2 mRNA] CTD PMID:16415329 methoxyacetic acid increases expression EXP 6480464 methoxyacetic acid results in increased expression of SLC38A2 mRNA CTD PMID:18199887 methylmercury chloride increases expression ISO RGD:736694 6480464 methylmercuric chloride results in increased expression of SLC38A2 mRNA CTD PMID:28001369 motexafin gadolinium multiple interactions ISO RGD:736694 6480464 motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of SLC38A2 mRNA], Zinc Acetate affects the reaction [motexafin gadolinium results in increased expression of SLC38A2 mRNA] CTD PMID:16357179 motexafin gadolinium increases expression ISO RGD:736694 6480464 motexafin gadolinium results in increased expression of SLC38A2 mRNA CTD PMID:16357179 N-acetyl-L-cysteine multiple interactions ISO RGD:736695 6480464 Acetylcysteine inhibits the reaction [arsenite results in increased expression of SLC38A2 mRNA] CTD PMID:22215663 N-methyl-4-phenylpyridinium decreases expression ISO RGD:736695 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of SLC38A2 protein CTD PMID:26558463 N-methylformamide increases expression ISO RGD:736695 6480464 methylformamide analog results in increased expression of SLC38A2 mRNA, methylformamide results in increased expression of SLC38A2 mRNA CTD PMID:17040096 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SLC38A2 mRNA, [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of SLC38A2 mRNA CTD PMID:18164116 , PMID:20360939 N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions EXP 6480464 Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of SLC38A2 mRNA] CTD PMID:16415329 nickel atom multiple interactions ISO RGD:736694 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of SLC38A2 mRNA] CTD PMID:14575637 nickel atom affects expression ISO RGD:736694 6480464 Nickel affects the expression of SLC38A2 mRNA CTD PMID:14575637 o-xylene increases expression ISO RGD:736694 6480464 2-xylene results in increased expression of SLC38A2 mRNA CTD PMID:20359517 ozone multiple interactions ISO RGD:736694 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of SLC38A2 mRNA more ... CTD PMID:32699268 paracetamol multiple interactions ISO RGD:736695 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of SLC38A2 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SLC38A2 mRNA] CTD PMID:17585979 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SLC38A2 mRNA CTD PMID:33387578 paracetamol affects expression ISO RGD:736695 6480464 Acetaminophen affects the expression of SLC38A2 mRNA CTD PMID:17562736 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:736694 6480464 perfluorooctane sulfonic acid results in decreased expression of SLC38A2 mRNA CTD PMID:32790152 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:736695 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC38A2 mRNA more ... CTD PMID:36331819 perfluorooctanoic acid decreases expression EXP 6480464 perfluorooctanoic acid results in decreased expression of SLC38A2 mRNA CTD PMID:16221955 perfluorooctanoic acid decreases expression ISO RGD:736694 6480464 perfluorooctanoic acid results in decreased expression of SLC38A2 mRNA CTD PMID:32790152 phenethyl caffeate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with caffeic acid phenethyl ester] results in decreased expression of SLC38A2 mRNA CTD PMID:20360939 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of SLC38A2 mRNA CTD PMID:31324951 phenobarbital decreases expression ISO RGD:736695 6480464 Phenobarbital results in decreased expression of SLC38A2 mRNA CTD PMID:19270015 phorone affects expression EXP 6480464 phorone affects the expression of SLC38A2 mRNA CTD PMID:18198479 pinosylvin increases expression ISO RGD:736694 6480464 pinosylvin results in increased expression of SLC38A2 mRNA CTD PMID:23333577 pirinixic acid increases expression ISO RGD:736695 6480464 pirinixic acid results in increased expression of SLC38A2 mRNA CTD PMID:18445702 pirinixic acid decreases expression ISO RGD:736695 6480464 pirinixic acid results in decreased expression of SLC38A2 mRNA CTD PMID:23811191 potassium chloride multiple interactions ISO RGD:736694 6480464 [Dronabinol results in decreased susceptibility to Potassium Chloride] which results in increased expression of SLC38A2 mRNA CTD PMID:29691375 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:736695 6480464 Pregnenolone Carbonitrile results in increased expression of SLC38A2 mRNA CTD PMID:28903501 progesterone increases expression ISO RGD:736694 6480464 Progesterone results in increased expression of SLC38A2 mRNA CTD PMID:18037150 progesterone multiple interactions ISO RGD:736695 6480464 [Estradiol co-treated with Progesterone] results in increased expression of SLC38A2 mRNA CTD PMID:18556351 propiconazole increases expression ISO RGD:736695 6480464 propiconazole results in increased expression of SLC38A2 mRNA CTD PMID:21278054 quercetin decreases expression ISO RGD:736694 6480464 Quercetin results in decreased expression of SLC38A2 mRNA CTD PMID:21632981 raloxifene increases expression ISO RGD:736694 6480464 Raloxifene Hydrochloride results in increased expression of SLC38A2 mRNA CTD PMID:16497877 ranitidine multiple interactions EXP 6480464 Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of SLC38A2 mRNA] CTD PMID:16415329 rifampicin decreases expression ISO RGD:736694 6480464 Rifampin results in decreased expression of SLC38A2 mRNA CTD PMID:27199754 rotenone affects expression EXP 6480464 Rotenone affects the expression of SLC38A2 mRNA CTD PMID:28374803 salubrinal multiple interactions ISO RGD:736695 6480464 salubrinal promotes the reaction [arsenic trioxide results in increased expression of SLC38A2 mRNA] CTD PMID:23892647 sevoflurane affects expression EXP 6480464 sevoflurane affects the expression of SLC38A2 mRNA CTD PMID:15967596 silicon dioxide increases expression ISO RGD:736694 6480464 Silicon Dioxide analog results in increased expression of SLC38A2 mRNA CTD PMID:25895662 sodium arsenite decreases expression ISO RGD:736694 6480464 sodium arsenite results in decreased expression of SLC38A2 mRNA CTD PMID:28595984 , PMID:34032870 sodium arsenite increases expression ISO RGD:736695 6480464 sodium arsenite results in increased expression of SLC38A2 mRNA CTD PMID:36209798 succimer multiple interactions ISO RGD:736695 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC38A2 mRNA CTD PMID:21641980 , PMID:23086747 sulindac increases expression ISO RGD:736694 6480464 Sulindac results in increased expression of SLC38A2 mRNA CTD PMID:11906190 sunitinib increases expression ISO RGD:736694 6480464 Sunitinib results in increased expression of SLC38A2 mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:736695 6480464 Tamoxifen affects the expression of SLC38A2 mRNA CTD PMID:20937368 testosterone increases expression ISO RGD:736695 6480464 Testosterone results in increased expression of SLC38A2 mRNA CTD PMID:20403060 testosterone decreases expression EXP 6480464 Testosterone results in decreased expression of SLC38A2 mRNA, Testosterone results in decreased expression of SLC38A2 protein CTD PMID:21812961 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of SLC38A2 mRNA CTD PMID:31150632 tetrachloromethane affects expression ISO RGD:736695 6480464 Carbon Tetrachloride affects the expression of SLC38A2 mRNA CTD PMID:31919559 thapsigargin increases expression ISO RGD:736694 6480464 Thapsigargin results in increased expression of SLC38A2 mRNA CTD PMID:29453283 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of SLC38A2 mRNA CTD PMID:34492290 titanium dioxide affects expression ISO RGD:736695 6480464 titanium dioxide affects the expression of SLC38A2 mRNA CTD PMID:17656681 , PMID:23557971 titanium dioxide increases expression ISO RGD:736695 6480464 titanium dioxide analog results in increased expression of SLC38A2 mRNA CTD PMID:25111187 toluene increases expression ISO RGD:736694 6480464 Toluene results in increased expression of SLC38A2 mRNA CTD PMID:20359517 toluene affects expression EXP 6480464 Toluene affects the expression of SLC38A2 mRNA CTD PMID:18653662 trans-pinosylvin increases expression ISO RGD:736694 6480464 pinosylvin results in increased expression of SLC38A2 mRNA CTD PMID:23333577 trichloroethene increases expression ISO RGD:736694 6480464 Trichloroethylene results in increased expression of SLC38A2 mRNA CTD PMID:20359517 trichostatin A multiple interactions ISO RGD:736694 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of SLC38A2 mRNA] CTD PMID:14575637 troglitazone decreases expression ISO RGD:736695 6480464 troglitazone results in decreased expression of SLC38A2 mRNA CTD PMID:28973697 tunicamycin increases expression ISO RGD:736694 6480464 Tunicamycin results in increased expression of SLC38A2 mRNA CTD PMID:29453283 urethane increases expression ISO RGD:736694 6480464 Urethane results in increased expression of SLC38A2 mRNA CTD PMID:28818685 valproic acid decreases expression ISO RGD:736695 6480464 Valproic Acid results in decreased expression of SLC38A2 mRNA CTD PMID:20546886 valproic acid affects expression ISO RGD:736694 6480464 Valproic Acid affects the expression of SLC38A2 mRNA CTD PMID:25979313 valproic acid decreases methylation ISO RGD:736694 6480464 Valproic Acid results in decreased methylation of SLC38A2 gene CTD PMID:29154799 valproic acid decreases expression ISO RGD:736694 6480464 Valproic Acid results in decreased expression of SLC38A2 mRNA CTD PMID:23179753 vancomycin decreases expression ISO RGD:736695 6480464 Vancomycin results in decreased expression of SLC38A2 mRNA CTD PMID:18930951 zidovudine decreases expression ISO RGD:736694 6480464 Zidovudine results in decreased expression of SLC38A2 mRNA CTD PMID:24292225 zinc acetate multiple interactions ISO RGD:736694 6480464 motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of SLC38A2 mRNA], Zinc Acetate affects the reaction [motexafin gadolinium results in increased expression of SLC38A2 mRNA] CTD PMID:16357179 zinc acetate increases expression ISO RGD:736694 6480464 Zinc Acetate results in increased expression of SLC38A2 mRNA CTD PMID:16357179 zinc atom multiple interactions ISO RGD:736694 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of SLC38A2 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:736694 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of SLC38A2 mRNA CTD PMID:18593933
